The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-7-(3-Hydroxy-3-methylpyrrolidin-1-yl)-5-(trifluoromethyl)-1H-pyrrolo[3,2-b]pyridine-6-carbonitrile ID: ALA4063606
PubChem CID: 137635756
Max Phase: Preclinical
Molecular Formula: C14H13F3N4O
Molecular Weight: 310.28
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: C[C@]1(O)CCN(c2c(C#N)c(C(F)(F)F)nc3cc[nH]c23)C1
Standard InChI: InChI=1S/C14H13F3N4O/c1-13(22)3-5-21(7-13)11-8(6-18)12(14(15,16)17)20-9-2-4-19-10(9)11/h2,4,19,22H,3,5,7H2,1H3/t13-/m0/s1
Standard InChI Key: KPYPGCUCWADQFY-ZDUSSCGKSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
13.0586 -10.5905 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7684 -10.9991 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7673 -10.1800 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.4822 -13.4877 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4811 -14.3073 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1891 -14.7162 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.1873 -13.0789 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8960 -13.4841 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9008 -14.3073 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6852 -14.5571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1652 -13.8883 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6774 -13.2253 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.7731 -14.7153 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0657 -14.3062 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
12.7724 -15.5325 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
12.0598 -15.1180 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
12.7744 -13.0793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0661 -12.6704 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.1849 -12.2617 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.8424 -11.7758 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5876 -10.9993 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5202 -11.7797 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
2 3 1 1
4 5 2 0
5 6 1 0
6 9 2 0
8 7 2 0
7 4 1 0
8 9 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 8 1 0
5 13 1 0
13 14 1 0
13 15 1 0
13 16 1 0
4 17 1 0
17 18 3 0
7 19 1 0
19 20 1 0
20 21 1 0
21 2 1 0
2 22 1 0
22 19 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 310.28Molecular Weight (Monoisotopic): 310.1041AlogP: 2.41#Rotatable Bonds: 1Polar Surface Area: 75.94Molecular Species: NEUTRALHBA: 4HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 1.06CX LogP: 2.01CX LogD: 2.01Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.85Np Likeness Score: -0.48
References 1. Huard K, Ahn K, Amor P, Beebe DA, Borzilleri KA, Chrunyk BA, Coffey SB, Cong Y, Conn EL, Culp JS, Dowling MS, Gorgoglione MF, Gutierrez JA, Knafels JD, Lachapelle EA, Pandit J, Parris KD, Perez S, Pfefferkorn JA, Price DA, Raymer B, Ross TT, Shavnya A, Smith AC, Subashi TA, Tesz GJ, Thuma BA, Tu M, Weaver JD, Weng Y, Withka JM, Xing G, Magee TV.. (2017) Discovery of Fragment-Derived Small Molecules for in Vivo Inhibition of Ketohexokinase (KHK)., 60 (18): [PMID:28853885 ] [10.1021/acs.jmedchem.7b00947 ]